Eli Lilly (LLY) vs AbbVie (ABBV)
Eli Lilly (LLY) and AbbVie (ABBV) side by side: both in Healthcare, both listed on New York Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 2.4×).
| Field | Eli Lilly | AbbVie |
|---|---|---|
| Legal name | Eli Lilly and Company | AbbVie Inc. |
| Ticker | LLY | ABBV |
| Exchange | New York Stock Exchange XNYS | New York Stock Exchange XNYS |
| Jurisdiction | United States | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $1.1tn | $451.5bn |
| Founded | 1876 | 2013 |
| Reporting currency | USD | USD |
| LEI | FRDRIPF3EKNDJ2CQJL29 | FR5LCKFTG8054YNNRU85 |
| ISIN | US5324571083 | US00287Y1091 |
| FIGI | BBG001S5STL8 | BBG0025Y4RZ3 |
| Index membership | S&P 500 | S&P 500 |
| Held by (covered funds) | 1 | — |
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
AbbVie
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
What they share
Same indices: S&P 500
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/eli-lilly · /api/v1/companies/abbvie